Search

Lincoln Pharmaceuticals

Sector: Healthcare | Industry: Drugs & Pharma
R 153.20 2.75  | 1.83% -34.15% 6.78 307.10
NSE Price: Oct 18, 15:46 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 18, 15:46 153.20 2.75 1.83% 149.00 150.45 10,760 149.00 - 156.80
BSE Oct 18, 2019 153.55 2.10 1.39% 153.65 151.45 3,995 152.00 - 156.65
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
6M Average Volume: 20,854 P/B: 1.09 NSE Code: LINCOLN
52-Week Range: R 124.35 - 275.90 Dividend Yield: 0.98% BSE Code: 531633
TTM EPS: R 22.63 Book Value: R 141.01 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Our equity analyst team has sifted through hundreds of companies and selected a short list of stocks that you should invest in.
This list now has 38 stocks on it. Thousands of our members are using stagnant equity markets to buy great stocks at low prices.

Membership is currently available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Lincoln Pharmaceuticals -31.85 0.62 -1.35 -33.75 -12.70 26.63 17.26
S&P BSE Small Cap -10.74 1.80 -3.18 -8.02 -0.38 4.94 5.38
S&P BSE Healthcare -9.25 -1.92 -2.85 -13.70 -8.12 -1.27 10.94
Company's return has been calculated on basis of BSE's price.
As on Oct 18, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 1.54 -2.91 11.71
Net Profit 40.66 26.99 36.77
EPS 40.69 18.82 30.11
Book Value 20.13 18.22 17.32
Average
Operating Margin 19.90 16.55 14.79
Net Margin 13.11 10.11 8.33
Return on Networth 19.75 17.89 17.50
Return on Investment 22.50 20.02 19.43
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 22.05 -3.01 22.05
Operating Profit 97.22 -20.51 97.22
Net Profit 49.67 -21.13 49.67
EPS 49.89 -21.15 49.89
TTM
Revenue -0.82 7.84 -0.82
Operating Profit -7.15 -7.26 -7.15
Net Profit -6.98 -1.11 -6.98
EPS -6.98 -1.12 -6.98
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Lincoln Pharmaceuticals 307.10 363.17 45.30 12.30 19.75 1.09 6.78
Astrazeneca Pharma India 5,689.63 771.42 69.56 8.84 20.03 17.77 81.79
Eris Lifesciences 5,793.71 1,005.70 303.64 29.29 28.96 4.70 19.08
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Mar 25, 2019 KAILASHBEN MAHENDRABHAI PATEL  Buy Inter-se Transfer 200,000 200.05 400.10
Mar 25, 2019 MAHENDRABHAI GULABDAS PATEL  Buy Inter-se Transfer 200,000 200.05 400.10
Mar 25, 2019 MANSI MUNJAL PATEL  Sell Inter-se Transfer 600,000 200.05 1,200.30
Mar 25, 2019 MUNJAL MAHENDRABHAI PATEL  Buy Inter-se Transfer 200,000 200.05 400.10
Jun 08, 2018 Kailashben Mahendrabhai Patel  Buy Market 50,000 224.95 112.48
News & Announcements
Contact Information

Company: Lincoln Pharmaceuticals Ltd.

Address: Lincoln House', Behind Satyam Complex, Science City Road, Sola, Ahmedabad, Gujarat - 380060 | Phone: 079-30018000 | Fax: 079-30018062

Email: [email protected]

Website: www.lincolnpharma.com

Registrar & Transfer Agent: Link Intime India Pvt Ltd.

Address: 506-508, 5th Floor, Amaranth Business Complex - I (ABC - I)Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura, Ahmedabad - 380009, 506-508, 5th Floor, Amaranth Business Complex - I (ABC - I), Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road, Navrangpura

Essential checks
Altman Z-Score
4.15
Piotroski F-Score
8
Modified C-Score
3
5-Years Price to Earnings
6.78
5-Years Price to Book
1.09
Earnings Yield
EBIT / Enterprise value
19.43%
PEG
Price / Earnings to growth ratio
0.19
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,278.35 -0.91%
Caplin Point Laboratories R396.85 +0.61%
Eris Lifesciences R422.60 +1.57%
FDC R160.90 -0.28%
JB Chemicals & Pharma R366.55 +2.03%
Laurus Labs R316.20 +1.92%
Strides Pharma Science R353.85 0.00%
Sun Pharma Adv. Research R132.50 +1.38%
Suven Life Sciences R280.55 +5.95%
Wockhardt R266.45 +2.80%
As on Oct 18, 15:59